1. Home
  2. TAOP vs NOTV Comparison

TAOP vs NOTV Comparison

Compare TAOP & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TAOP

Taoping Inc.

HOLD

Current Price

$1.35

Market Cap

12.1M

Sector

Technology

ML Signal

HOLD

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.28

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAOP
NOTV
Founded
1993
1974
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1M
12.4M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
TAOP
NOTV
Price
$1.35
$0.28
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
74.1K
408.1K
Earning Date
10-01-2025
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,196,786.00
$514,027,000.00
Revenue This Year
N/A
$6.49
Revenue Next Year
N/A
$4.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.19
52 Week Low
$1.19
$0.28
52 Week High
$20.10
$4.51

Technical Indicators

Market Signals
Indicator
TAOP
NOTV
Relative Strength Index (RSI) 43.27 20.09
Support Level $1.24 $0.33
Resistance Level $1.39 $0.50
Average True Range (ATR) 0.21 0.05
MACD -0.02 -0.01
Stochastic Oscillator 15.38 0.23

Price Performance

Historical Comparison
TAOP
NOTV

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: